Skip to main content
Equibles

MORGAN STANLEY

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 895421 NEW YORK, NY
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,388,365
-$3,632,001 QoQ
Shares Held
728,817
-16.2% QoQ
Ownership
0.643%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 215 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VRDN ranks #123 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in VRDN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,388,365 728,817
2026-03-31 $17,020,366 870,162
2025-12-31 $54,093,559 1,738,225
2025-09-30 $4,142,084 191,941
2025-06-30 $2,801,126 200,367
2025-03-31 $4,607,393 341,795
2024-12-31 $14,169,311 739,140
2024-09-30 $22,974,744 1,009,879
2024-06-30 $4,170,612 320,570
2024-03-31 $9,850,088 562,541
2023-12-31 $11,432,340 524,901
2023-09-30 $5,119,306 333,723
2023-06-30 $1,657,658 69,679
2023-03-31 $11,018,925 433,134
2022-12-31 $9,794,168 335,302
2022-09-30 $3,379,182 164,758
2022-06-30 $319,133 27,583
2022-03-31 $645,836 34,929
2021-12-31 $270,748 13,695
2021-09-30 $163,215 9,922
2021-06-30 $127,755 6,985